Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Cisplatin Combined With Topotecan in Advanced (Stage IVB) Recurrent or Persistent Cervical Cancer

NCT00826891 is registered in ClinicalTrials.gov with Chinese Anti-Cancer Association as lead sponsor.

NCT NCT00826891
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00826891 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Cisplatin Combined With Topotecan in Advanced (Stage IVB) Recurrent or Persistent Cervical Cancer
Lead sponsor
Chinese Anti-Cancer Association
Phase
Phase 2
Overall status
Unknown status
Start date
February 28, 2009
Completion date
January 31, 2010
Enrollment
40 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer